Information Library

Results for: Capital - Emerging Biopharma

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Emerging Biopharma Service Fact Sheet

    Brochure — May 4, 2010
    Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies.

  • PharmAsia News Article Reprint

    Media Coverage — March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • Enabling Transformation

    Case Study — September 30, 2009
    Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company.

  • Should Venture Firms Bundle Their Biotech Portfolios?

    Media Coverage — June 29, 2009
    Ron Wooten, president of the investment and business-development unit of Quintiles, a contract-research organization, thinks so.

Page 1 of 1 (4 results)

Subscribe to Email Based on Your Interests

Set preferences